Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains.

Douglas B KellMartin J PageLize EngelbrechtGraham C EllisDouglas B Kell

Published in: Cardiovascular diabetology (2017)

This implies strongly that there is indeed a microbial component to the development of type 2 diabetes, and suggests that LBP might be used as treatment for it and its sequelae.

Keyphrases

type diabetes
microbial community
quantum dots
cardiovascular disease
glycemic control
living cells
combination therapy
replacement therapy
smoking cessation